OBJECTIVE: To describe the methodology and baseline results of the Spanish cohort of naïve HIV-infected patients included in the Research Network on HIV/AIDS (CoRIS). METHODS: CoRIS is a multicenter, hospital-based prospective cohort of HIV sero-prevalent, retroviral-naïve subjects, over 13 years old, and seen at 17 hospitals in 8 of the 17 Autonomous Regions in Spain from January 2004 to October 2005. The socio-demographic characteristics, as well as epidemiological, clinical, laboratory and treatment data were recorded, and biological samples were collected at baseline and during follow-up. RESULTS: A total of 1,591 subjects have been included in CoRIS; 24% are women, median age at cohort entry is 36 years, and 74% were diagnosed during 2004 or 2005. Twenty-seven percent came from countries other than Spain, mainly Latin-America (16%) and sub-Saharan Africa (5%). Thirty-two percent had completed secondary education and 16% university studies. The most frequent categories of transmission were men having sex with men (37%) and heterosexual sex (36%); only 21% were injection drug users. At cohort entry, median CD4 count was 317 cells/mm 3 and median viral load was 52,300 copies/mL; 18% were diagnosed with AIDS. Main AIDS-defining illnesses were Pneumocystis jiroveci pneumonia (6.1%), esophageal candidiasis (3.3%) and tuberculosis (extrapulmonary, 3.0% and pulmonary 2.7%). There were 35 deaths (2.2%). Thirty-three percent of patients gave a baseline sample to the BioBank. CONCLUSIONS: CoRIS offers relevant information about the current epidemiological profile of HIV infection in Spain, where sexual transmission has become predominant. The type and amount of information obtained from clinical and epidemiological data collection together with biological samples demonstrate the viability of the project, which offers many possibilities for future research.
OBJECTIVE: To describe the methodology and baseline results of the Spanish cohort of naïve HIV-infectedpatients included in the Research Network on HIV/AIDS (CoRIS). METHODS: CoRIS is a multicenter, hospital-based prospective cohort of HIV sero-prevalent, retroviral-naïve subjects, over 13 years old, and seen at 17 hospitals in 8 of the 17 Autonomous Regions in Spain from January 2004 to October 2005. The socio-demographic characteristics, as well as epidemiological, clinical, laboratory and treatment data were recorded, and biological samples were collected at baseline and during follow-up. RESULTS: A total of 1,591 subjects have been included in CoRIS; 24% are women, median age at cohort entry is 36 years, and 74% were diagnosed during 2004 or 2005. Twenty-seven percent came from countries other than Spain, mainly Latin-America (16%) and sub-Saharan Africa (5%). Thirty-two percent had completed secondary education and 16% university studies. The most frequent categories of transmission were men having sex with men (37%) and heterosexual sex (36%); only 21% were injection drug users. At cohort entry, median CD4 count was 317 cells/mm 3 and median viral load was 52,300 copies/mL; 18% were diagnosed with AIDS. Main AIDS-defining illnesses were Pneumocystis jiroveci pneumonia (6.1%), esophageal candidiasis (3.3%) and tuberculosis (extrapulmonary, 3.0% and pulmonary 2.7%). There were 35 deaths (2.2%). Thirty-three percent of patients gave a baseline sample to the BioBank. CONCLUSIONS: CoRIS offers relevant information about the current epidemiological profile of HIV infection in Spain, where sexual transmission has become predominant. The type and amount of information obtained from clinical and epidemiological data collection together with biological samples demonstrate the viability of the project, which offers many possibilities for future research.
Authors: Gonzalo Yebra; Miguel de Mulder; Leticia Martín; Carmen Rodríguez; Pablo Labarga; Isabel Viciana; Juan Berenguer; María Remedios Alemán; Juan Antonio Pineda; Federico García; Africa Holguín Journal: J Clin Microbiol Date: 2011-12-07 Impact factor: 5.948
Authors: José R Blanco; Inmaculada Jarrín; Manuel Vallejo; Juan Berenguer; Carmen Solera; Rafael Rubio; Federico Pulido; Victor Asensi; Julia del Amo; Santiago Moreno Journal: AIDS Res Hum Retroviruses Date: 2012-09 Impact factor: 2.205
Authors: Michael J Mugavero; Margaret May; Heather J Ribaudo; Roy M Gulick; Sharon A Riddler; Richard Haubrich; Sonia Napravnik; Sophie Abgrall; Andrew Phillips; Ross Harris; M John Gill; Frank de Wolf; Robert Hogg; Huldrych F Günthard; Geneviève Chêne; Antonella D'Arminio Monforte; Jodie L Guest; Colette Smith; Javier Murillas; Juan Berenguer; Christoph Wyen; Pere Domingo; Mari M Kitahata; Jonathan A C Sterne; Michael S Saag Journal: J Acquir Immune Defic Syndr Date: 2011-11-01 Impact factor: 3.731
Authors: Maile Ray; Roger Logan; Jonathan A C Sterne; Sonia Hernández-Díaz; James M Robins; Caroline Sabin; Loveleen Bansi; Ard van Sighem; Frank de Wolf; Dominique Costagliola; Emilie Lanoy; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casbona; Julia del Amo; Santiago Moreno; Amy Justice; Joseph Goulet; Sara Lodi; Andrew Phillips; Rémonie Seng; Laurence Meyer; Santiago Pérez-Hoyos; Patricia García de Olalla; Miguel A Hernán Journal: AIDS Date: 2010-01-02 Impact factor: 4.177
Authors: Patricia Garcia de Olalla; Christian Manzardo; Maria A Sambeat; Inma Ocaña; Hernando Knobel; Victoria Humet; Pere Domingo; Esteve Ribera; Ana Guelar; Andres Marco; Maria J Belza; Josep M Miró; Joan A Caylà Journal: AIDS Res Ther Date: 2011-07-06 Impact factor: 2.250
Authors: Santiago Pérez Cachafeiro; Ana María Caro-Murillo; Juan Berenguer; Ferran Segura; Felix Gutierrez; Francesc Vidal; Maria Angeles Martinez-Perez; Julio Sola; Roberto Muga; Santiago Moreno Journal: Emerg Infect Dis Date: 2011-06 Impact factor: 6.883
Authors: Lourdes Domínguez-Domínguez; Marta Rava; José Antonio Iribarren; Santiago Moreno; Otilia Bisbal; Luis Lopez-Cortés; Joaquín Portilla; Daniel Podzamczer; Julián Olalla; Daniel Fuster; Rafael Rubio; Inmaculada Jarrín Journal: BMC Infect Dis Date: 2022-04-15 Impact factor: 3.667